The healthcare sector generates massive volumes of data, which has “immense potential” to protect and promote health and to improve healthcare and cure, according to the EU’s Health Commissioner Vytenis Andriukaitis. Speaking at the “Big Data: Connected solutions for better healthcare” conference held in Brussels last week (25-26 January), the EU health chief stressed the importance of big data in healthcare, saying that its usage could identify patterns that will, in turn, lead to new prevention, diagnostic and therapeutic techniques. “At the same time, it could decrease inefficiencies and reduce waste, time and resources,” Andriukaitis noted.
He singled out the importance of the European Reference Networks, whose aim is to provide cross-border healthcare cooperation between European countries to treat rare and complex diseases. “The success of ERNs also depends on big data: they will compile fragmented health data sets, generate new clinical, genetic, behavioural, and environmental data and make use of these data,” the EU official said.
Read the full article published by Euractive.com.
Connected article: Data is the new blood.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
